Wave Life Sciences

Wave Life Sciences is a clinical stage genetic medicine company. The Company is utilizing its synthetic chemistry platform to design and develop nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, with a goal of delivering new and exceptional treatment options for patients. Wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi, potentially enabling it to address a broad range of therapeutic areas and diseases.

Company Growth (employees)
Type
Public
HQ
Cambridge, US
Founded
2012
Size (employees)
96 (est)+135%
Wave Life Sciences was founded in 2012 and is headquartered in Cambridge, US

Wave Life Sciences Office Locations

Wave Life Sciences has an office in Cambridge
Cambridge, US (HQ)
733 Concord Ave

Wave Life Sciences Financials and Metrics

Wave Life Sciences Financials

Wave Life Sciences's revenue was reported to be $1.5 m in FY, 2016
USD

Revenue (FY, 2016)

1.5 m

Revenue growth (FY, 2015 - FY, 2016), %

877%

Net income (FY, 2016)

(55.4 m)

EBIT (FY, 2016)

(55.3 m)

Market capitalization (11-Dec-2017)

1.1 b

Cash (31-Dec-2016)

150.3 m
Wave Life Sciences's current market capitalization is $1.1 b.
USDFY, 2015FY, 2016

Revenue

152 k1.5 m

Revenue growth, %

877%

R&D expense

9.1 m40.8 m

General and administrative expense

10.4 m16 m
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

152 k26 k417 k392 k

R&D expense

2.1 m4.7 m8.4 m13.7 m

General and administrative expense

2.9 m3.2 m3.7 m3.9 m

Operating expense total

5 m8 m12.1 m17.6 m
USDFY, 2015FY, 2016

Cash

161.2 m150.3 m

Accounts Receivable

200 k

Inventories

146 k1.5 m

Current Assets

161.4 m152 m
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

66 m153.4 m181.8 m169 m

Accounts Receivable

200 k2.5 m

Current Assets

68 m154 m183.9 m172.1 m

PP&E

2 m3.2 m5.1 m6.7 m
USDFY, 2015FY, 2016

Net Income

(19.2 m)(55.4 m)

Depreciation and Amortization

594 k784 k

Accounts Receivable

193 k193 k

Inventories

(63 k)(1.3 m)
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

(4.9 m)(7.8 m)(11.6 m)(17.5 m)

Accounts Receivable

200 k2.5 m

Accounts Payable

2.9 m2.4 m3.9 m3.8 m
USDY, 2016

Revenue/Employee

36.2 k

Financial Leverage

1.2 x
Show all financial metrics

Wave Life Sciences Operating Metrics

FY, 2016

Phase II Trials

3

Patents Issued

27

Patents Pending

22

Phase I Trials

20
Show all operating metrics

Wave Life Sciences Market Value History

Wave Life Sciences's Web-traffic and Trends

Wave Life Sciences Online and Social Media Presence

Wave Life Sciences Company Life and Culture

You may also be interested in